ISSN: 2349-5162 | Impact Factor: 5.87

JETIREXPLORE- Search Thousands of research papers



Published in:

Volume 5 Issue 1
January-2018
eISSN: 2349-5162

Unique Identifier

JETIR1801027

Page Number

141-150

Share This Article


Indexing Partner


Title

A Study of Method Development and Validation for Quantification of Iguratimod in Pharmaceutical Dosage Form by RP-HPLC Method

ISSN

2349-5162

Cite This Article

"A Study of Method Development and Validation for Quantification of Iguratimod in Pharmaceutical Dosage Form by RP-HPLC Method", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 1, page no.141-150, January-2018, Available :http://www.jetir.org/papers/JETIR1801027.pdf

Abstract

A rapid and stability-indicating reversed phase high-performance liquid chromatography (RP-HPLC) method was developed for quantification of Iguratimod in the dosage form to get some more advantages over other methods already developed. The method was validated according to United States Pharmacopeia (USP) guideline with respect to accuracy, precision, specificity, linearity, solution stability, robustness and system suitability. For this, an isocratic condition of mobile phase comprising buffer (pH 2.5) and methanol in a ratio of 58:42, v/v at a flow rate of 1.2 mL/minute over Water symmetry C18, 150 × 3.9 mm, 5μm) column at 25°C temperature was maintained. The method showed excellent linear response with correlation coefficient (R2) values of 0.999 for Iguratimod, which was within the limit of correlation coefficient (R2≥0.995). The percent recovery was found within the acceptance limit of (97.0–103.0%). Intra-and inter-day precision studies of the new method were less than the maximum allowable limit percentage of relative standard deviation (%RSD≤2.0).

Key Words

RP-HPLC, Validation

Cite This Article

"A Study of Method Development and Validation for Quantification of Iguratimod in Pharmaceutical Dosage Form by RP-HPLC Method", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 1, page no. pp141-150, January-2018, Available at : http://www.jetir.org/papers/JETIR1801027.pdf

Publication Details

Published Paper ID: JETIR1801027
Registration ID: 171235
Published In: Volume 5 | Issue 1 | Year January-2018
DOI (Digital Object Identifier):
Page No: 141-150
ISSN Number: 2349-5162

Download Paper

Preview Article

Download Paper


UGC and ISSN Approved Journal | Call For Paper
(Volume 5 | Issue 10 | October 2018 |Impact factor 5.87)

Call For Paper | Volume 5 | Issue 10 | Impact factor 5.87


Cite This Article

"A Study of Method Development and Validation for Quantification of Iguratimod in Pharmaceutical Dosage Form by RP-HPLC Method", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 1, page no. pp141-150, January-2018, Available at : http://www.jetir.org/papers/JETIR1801027.pdf

Important Dates Related to Publication Procedure:
  • » Paper Submission Till: 29 October 2018.
  • » UGC and ISSN Approved Journal
  • » Review (Acceptance/Rejection) Notification: Within 02-04 Days.
  • » Paper Publish:Within 02-07 Days after submitting the all documents.
  • » Frequency: Monthly (12 issue Annually)
  • » Journal Type : Open Access
  • »Indexing In Google Scholar, ResearcherID Thomson Reuters, Mendeley : reference manager, Academia.edu, arXiv.org, Research Gate, CiteSeerX, DocStoc, ISSUU, Scribd, and many more | High Impact Factor: 5.87 Digital object identifier (DOI) and Hard Copy of certificate Provided.
Publication and Indexing Patner:




Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0001027

Print This Page

Impact Factor

Impact factor: 5.87